Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Wed, 28 Jun 17 10:10:48 +0000 Wed, 28 Jun 17 10:10:48 +0000 Physician Charged in Pill Mill Operation http://www.pharmacytimes.com/news/physician-charged-in-pill-mill-operation http://www.pharmacytimes.com/news/physician-charged-in-pill-mill-operation A Staten Island physician was recently charged for his involvement in an oxycodone distribution conspiracy that yielded the diversion of millions of dollars&rsquo; worth of pain medication.&nbsp;<br /> &nbsp; Tue, 27 Jun 17 12:00:00 +0000 Venous Thromboembolism Prophylaxis Gets FDA Approval http://www.pharmacytimes.com/news/venous-thromboembolism-prophylaxis-gets-fda-approval http://www.pharmacytimes.com/news/venous-thromboembolism-prophylaxis-gets-fda-approval Bevyxxa has been approved based on data from Portola&#39;s phase 3 APEX Study.&nbsp; Fri, 23 Jun 17 18:25:02 +0000 Blood Cancer Treatment Gets FDA Nod http://www.pharmacytimes.com/product-news/blood-cancer-treatment-gets-fda-nod http://www.pharmacytimes.com/product-news/blood-cancer-treatment-gets-fda-nod The approval is based on multiple clinical trials, and provides patients with a subcutaneous option for rituximab that shortens the treatment time to 5 to 7 minutes compared with intravenous infusion. Fri, 23 Jun 17 01:23:34 +0000 FDA Approves C1 Esterase Inhibitor to Treat Genetic Disease http://www.pharmacytimes.com/news/fda-approves-c1-esterase-inhibitor-to-treat-genetic-disease http://www.pharmacytimes.com/news/fda-approves-c1-esterase-inhibitor-to-treat-genetic-disease Thu, 22 Jun 17 22:50:18 +0000 EMDAC Panel: Liraglutide Linked with Reduced CVD Risk in T2DM Patients http://www.pharmacytimes.com/product-news/emdac-panel-liraglutide-linked-with-reduced-cvd-risk-in-t2dm-patients- http://www.pharmacytimes.com/product-news/emdac-panel-liraglutide-linked-with-reduced-cvd-risk-in-t2dm-patients- The discussions at the Advisory Committee meeting were based on data from the LEADER trial.&nbsp; Wed, 21 Jun 17 14:58:49 +0000 ADHD Drug Gets FDA Nod http://www.pharmacytimes.com/news/adhd-drug-gets-fda-nod http://www.pharmacytimes.com/news/adhd-drug-gets-fda-nod Mydayis is not for use in children 12 years and younger. Wed, 21 Jun 17 07:55:24 +0000 FDA Approves First Orally Dissolvable Methylphenidate Tablets for ADHD http://www.pharmacytimes.com/product-news/fda-approves-first-orally-dissolvable-methylphenidate-tablets-for-adhd http://www.pharmacytimes.com/product-news/fda-approves-first-orally-dissolvable-methylphenidate-tablets-for-adhd The FDA has approved Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets from Neos Therapeutics, the company announced in a press release.&nbsp; Tue, 20 Jun 17 20:45:49 +0000 Study: Pharmacists Often Have Better Penicillin Allergy Knowledge Than Other Health Professionals http://www.pharmacytimes.com/news/study-pharmacists-often-have-better-penicillin-allergy-knowledge-than-other-health-professionals http://www.pharmacytimes.com/news/study-pharmacists-often-have-better-penicillin-allergy-knowledge-than-other-health-professionals Pharmacists appear to have a better understanding of penicillin allergies than other health care professionals, according to study that included 276 surveys completed by non-allergist physicians, nurse practitioners, and pharmacists at Rochester Regional Health. Tue, 20 Jun 17 13:11:38 +0000 FDA Approves Skin Infection Antibiotic http://www.pharmacytimes.com/news/fda-approves-skin-infection-antibiotic http://www.pharmacytimes.com/news/fda-approves-skin-infection-antibiotic New fluoroquinolone provides options for serious skin infection treatment.&nbsp; Mon, 19 Jun 17 21:35:08 +0000 FDA Orders Dermatology Drug Manufacturer to Shut Down http://www.pharmacytimes.com/news/fda-orders-dermatology-drug-manufacturer-to-shut-down- http://www.pharmacytimes.com/news/fda-orders-dermatology-drug-manufacturer-to-shut-down- The products include those intended for dermatological purposes, for instance, ointments, washes and creams that were never tested or approved to be sold in retail stores. Fri, 16 Jun 17 09:59:01 +0000 Topical Products Voluntarily Recalled Due to Unsafe Manufacturing http://www.pharmacytimes.com/news/topical-products-voluntarily-recalled-due-to-unsafe-manufacturing- http://www.pharmacytimes.com/news/topical-products-voluntarily-recalled-due-to-unsafe-manufacturing- Summer is approaching, and that means more scrapes, burns, and rashes as more people head outdoors, but 9 products used to treat these conditions are being recalled. Thu, 15 Jun 17 14:22:46 +0000 FDA Meeting to Focus on Abuse-Deterrent Opioids http://www.pharmacytimes.com/news/fda-meeting-to-focus-on-abusedeterrent-opioids http://www.pharmacytimes.com/news/fda-meeting-to-focus-on-abusedeterrent-opioids Officials with the FDA noted this this public meeting is designed to bring new ideas to the table on how to combat drug addiction in the most effective way possible. Wed, 14 Jun 17 19:05:45 +0000 2017 Top Recommended Health Products http://www.pharmacytimes.com/news/2017-top-recommended-health-products http://www.pharmacytimes.com/news/2017-top-recommended-health-products Consumers and health care professionals can visit U.S. News Top Recommended Health Products and www.otcguide.net to see the collective recommendations of thousands of pharmacists for more than 1,100 over-the-counter brands, representing 163 product categories. Tue, 13 Jun 17 12:58:41 +0000 FDA Requests Reformulated Oxymorphone Product Removed for Abuse Risk http://www.pharmacytimes.com/news/fda-requests-reformulated-oxymorphone-product-removed-for-abuse-risk http://www.pharmacytimes.com/news/fda-requests-reformulated-oxymorphone-product-removed-for-abuse-risk This is the first time the agency has taken steps to remove a currently marketed opioid pain medication from sale due to the public health consequences of abuse Thu, 08 Jun 17 21:29:28 +0000 HPV Vaccine Reduces High-Risk Infections, But Are People Getting Vaccinated? http://www.pharmacytimes.com/news/hpv-vaccine-reduces-highrisk-infections-but-are-people-getting-vaccinated http://www.pharmacytimes.com/news/hpv-vaccine-reduces-highrisk-infections-but-are-people-getting-vaccinated HPV vaccination is currently indicated for the prevention of cervical, vulvar, and vaginal cancers in women, and anal cancers in both women and men. Sun, 04 Jun 17 06:18:28 +0000 Web-Based System for Self-Reporting Symptoms Helping Patients Live Longer http://www.pharmacytimes.com/news/webbased-system-for-selfreporting-symptoms-helping-patients-live-longer http://www.pharmacytimes.com/news/webbased-system-for-selfreporting-symptoms-helping-patients-live-longer Sun, 04 Jun 17 05:55:21 +0000 Biosimilars, Oncology and the Pharmaceutical Industry: What's the Next Step? http://www.pharmacytimes.com/news/biosimilars-oncology-and-the-pharmaceutical-industry-whats-the-next-step- http://www.pharmacytimes.com/news/biosimilars-oncology-and-the-pharmaceutical-industry-whats-the-next-step- The impact that generics have on bringing down the cost of branded drugs needs to happen in the biologics space so the industry can save money and improve access to medications and population outcomes. Sun, 04 Jun 17 05:33:22 +0000 What's Next for Multidisciplinary Care? http://www.pharmacytimes.com/news/whats-next-for-multidisciplinary-care http://www.pharmacytimes.com/news/whats-next-for-multidisciplinary-care Mark S. Soberman, MD, MBA, FACS, the 2017 to 2018 President of the Association of Community Cancer Centers (ACCC), discusses his vision for the next-generation of multidisciplinary care in an interview during the 2017 ASCO Annual Meeting.&nbsp; Sun, 04 Jun 17 05:15:30 +0000 5 New FDA Approvals to Know from May 2017 http://www.pharmacytimes.com/news/5-new-fda-approvals-to-know-from-may-2017 http://www.pharmacytimes.com/news/5-new-fda-approvals-to-know-from-may-2017 Learn about the new products and expanded indications approved by the FDA in May 2017. Fri, 02 Jun 17 15:30:08 +0000 FDA Expands Ceritinib Indication http://www.pharmacytimes.com/news/fda-expands-ceritinib-indication http://www.pharmacytimes.com/news/fda-expands-ceritinib-indication In 2014, the drug was granted accelerated approval to treat patients with ALK-positive NSCLC whose disease progressed on or who are intolerant to crizotinib.&nbsp; Wed, 31 May 17 19:24:10 +0000 Once Daily HIV Drug Gets Nod http://www.pharmacytimes.com/news/once-daily-hiv-drug-gets-nod http://www.pharmacytimes.com/news/once-daily-hiv-drug-gets-nod Isentress has been used as a component of treatment regimens for patients diagnosed with HIV-1 for almost a decade.&nbsp; Wed, 31 May 17 18:45:18 +0000 Oral Contraceptives Recalled for Out-of-Sequence Packaging http://www.pharmacytimes.com/product-news/oral-contraceptives-recalled-for-outofsequence-packaging http://www.pharmacytimes.com/product-news/oral-contraceptives-recalled-for-outofsequence-packaging Lupin Pharmaceuticals Inc. has issued a nationwide recall of 1 lot of its oral contraceptive tablets Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate) &nbsp;because of out-of-sequence tablet packaging and missing expiration and lot information.&nbsp; Tue, 30 May 17 19:20:04 +0000 DNA Test Targets Best Antibiotic Treatment for Gonorrhea http://www.pharmacytimes.com/news/dna-test-targets-best-antibiotic-treatment-for-gonorrhea http://www.pharmacytimes.com/news/dna-test-targets-best-antibiotic-treatment-for-gonorrhea Researchers from UCLA have developed a laboratory test that could potentially identify gonorrhea infections that may be more treatable with antibiotics.&nbsp; Thu, 25 May 17 12:00:00 +0000 Equashield to Open New $30 Million Manufacturing Facility to Accommodate Future Growth in Product Portfolio and Increase Production Capabilities http://www.pharmacytimes.com/news/equashield-to-open-new-30-million-manufacturing-facility-to-accommodate-future-growth-in-product-portfolio-and-increase-production-capabilities http://www.pharmacytimes.com/news/equashield-to-open-new-30-million-manufacturing-facility-to-accommodate-future-growth-in-product-portfolio-and-increase-production-capabilities Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for the safe and simple handling of hazardous drugs, today held a groundbreaking for a new manufacturing plant. Wed, 24 May 17 00:00:00 +0000 Smart Trap Increasingly Accurate in Catching Zika, West Nile Mosquitoes http://www.pharmacytimes.com/news/smart-trap-increasingly-accurate-in-catching-zika-west-nile-mosquitoes http://www.pharmacytimes.com/news/smart-trap-increasingly-accurate-in-catching-zika-west-nile-mosquitoes Houston Public Media today reported on a &ldquo;smart trap&rdquo; by Microsoft&nbsp;that Harris County Mosquito Control has been testing since summer 2016. Tue, 23 May 17 12:00:00 +0000